Evidence forras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline–induced colonic aberrant crypts in the rat
- 1 April 1995
- journal article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 12 (4) , 187-192
- https://doi.org/10.1002/mc.2940120402
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk dietCarcinogenesis: Integrative Cancer Research, 1994
- Carcinogenic factors in food with relevance to colon cancer developmentMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesisCarcinogenesis: Integrative Cancer Research, 1993
- Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague—Dawley rats: earliest recognizable precursor lesions of experimental colon cancerCarcinogenesis: Integrative Cancer Research, 1992
- Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytateCarcinogenesis: Integrative Cancer Research, 1992
- Induction of Aberrant Crypt Foci in the Large Intestine of F344 Rats by Oral Administration of 2-Amino-l-methyl-6-phenylimidazo[4,5-b]pyridineJapanese Journal of Cancer Research, 1991
- A genetic model for colorectal tumorigenesisCell, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Detection of high incidence of K-ras oncogenes during human colon tumorigenesisNature, 1987
- Prevalence of ras gene mutations in human colorectal cancersNature, 1987